Given that TP53 and PI3K/AKT pathway alterations have been implicated in immune evasion,40-43 future research integrating genomic and immune profiling could clarify how these alterations shape the tumor microenvironment and influence immunotherapy responses. The gene discussed is PIK3CA; the disease is neoplasm.